TABLE 1.
VHL status | Treatment | Tumor take rate (%) (no. of samples with tumors/total no. of samples) |
---|---|---|
Deficient | Vehicle (n = 21) | 81.0 (17/21) |
Reconstituted | Vehicle (n = 9) | 11.1 (1/9) |
Deficient | Sunitinib (n = 21) | 57.1 (12/21) |
VHL status | Treatment | Tumor take rate (%) (no. of samples with tumors/total no. of samples) |
---|---|---|
Deficient | Vehicle (n = 21) | 81.0 (17/21) |
Reconstituted | Vehicle (n = 9) | 11.1 (1/9) |
Deficient | Sunitinib (n = 21) | 57.1 (12/21) |